Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

YUSUF SERHAT İŞ

Doktor Öğretim Üyesi

Doğuş Üniversitesi Meslek Yüksekokulu Çevre Koruma Teknolojileri Bölümü

Research topics OpenAlex
  1. Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  2. Yan Dal Kimya
Keywords YÖKSİS
Articles 7 YÖKSİS 7 · OpenAlex 0 Total citations 80 h-index 5 · OpenAlex OpenAlex coverage %86 matched 6 / 7 Q1 articles 2 Scopus · WoS Q1 2 Co-authors 10 3 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 6 + YÖKSİS · co-author record: 1
h-index 5 Percentile in Türkiye: 60 #35 of 282 at their university by h-index
i10-index
4
Total citations
80
Top 41% in Türkiye
Per article
11.4
FWCI
0.98
1.00 = world average
World top 1%
0
World top 10%
1

Most cited articles

  1. Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties 2018 world top 10% 34 citations
  2. A QM protein–ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R) 2018 15 citations
  3. Deciphering the mechanism and binding interactions of Pemetrexed with dsDNA with DNA-targeted chemotherapeutics via spectroscopic, analytical, and simulation studies 2021 14 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (0 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Citing publications Crossref 25 publications citing 7 DOI-bearing articles · 5 Türkiye-affiliated
  • 2019 9
  • 2020 8
  • 2021 6
  • 2025 1
  • 2026 1
  1. DOI 10.1016/j.molstruc.2025.144847 2026
  2. DOI 10.1002/adts.202501486 2025
  3. Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo TR Ferah Comert Onder et al. · ACS Pharmacology & Translational Science · 2021
  4. Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combinedin silicoandin vitroStudy TR Serdar Durdagi et al. · Molecular Informatics · 2021
  5. DOI 10.3390/molecules26082193 2021
  6. DOI 10.1021/acschemneuro.1c00430 2021
  7. DOI 10.1007/978-3-030-62226-8_20 2021
  8. DOI 10.1007/978-3-030-70542-8_15 2021
  9. Design, Synthesis, and Molecular Modeling Studies of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors TR Ferah Comert Onder et al. · Journal of Chemical Information and Modeling · 2020
  10. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2 TR Gurbet Tutumlu et al. · Frontiers in Chemistry · 2020
  11. Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors TR Yusuf Serhat Is et al. · Journal of Chemical Information and Modeling · 2020
  12. DOI 10.1007/978-981-15-6815-2_4 2020
  13. DOI 10.2174/1386207323666200324173231 2020
  14. DOI 10.1016/j.jep.2019.112305 2020
  15. DOI 10.1016/j.cdc.2020.100574 2020
  16. DOI 10.3390/antiox9080714 2020
  17. DOI 10.1021/acs.biochem.9b00213 2019
  18. DOI 10.1007/s11030-019-09917-8 2019
  19. DOI 10.1371/journal.pone.0224691 2019
  20. DOI 10.3390/molecules24214003 2019
  21. DOI 10.3390/molecules24071196 2019
  22. DOI 10.1007/978-1-4939-9752-7_8 2019
  23. DOI 10.1039/c9nj03353j 2019
  24. DOI 10.1007/978-1-4939-9752-7_6 2019
  25. DOI 10.1002/med.21561 2019
Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Field ranking

Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.

YÖKSİS ?
Keyword rankings 2

Works 7

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%1
Avg · n 6 %73.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 7

WoS (JCR)

  • YÖKSİS rows 6

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

7articles

Journals with publications

5 journals

Narrow down

Scopus (SJR)
Q12 Q22 Q31 Q42
WoS (JCR)
Q12 Q21 Q33 Q40
TR Index
0articles

Article list

  1. 2026 Unveiling the molecular interactions of flavonoid derivatives as human aldose reductase inhibitors: a detailed DFT-based per-residue interaction energy mapping JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS DOI 10.1080/07391102.2026.2683865 YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.7%
  2. 2022 Investigation of the interactions of anticancer drugs with tyrosine kinase enzyme using semiempirical methods and comparisons with DFT Calculations Turkish Computational and Theoretical Chemistry DOI 10.33435/tcandtc.1055649 YÖKSİS SJR Q3
  3. 2021 Elucidation of ligand/protein interactions between BCR-ABL tyrosine kinase and some commercial anticancer drugs via DFT methods Journal of Computational Biophysics and Chemistry YÖKSİS SJR Q4 JCR Q3 OpenAlex 71.2%
  4. 2021 Deciphering the mechanism and binding interactions of Pemetrexed with dsDNA with DNA-targeted chemotherapeutics via spectroscopic, analytical, and simulation studies Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2021.114490 YÖKSİS SJR Q4 JCR Q3 OpenAlex 69.1%
  5. 2020 Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors Journal of Chemical Information and Modeling DOI 10.1021/acs.jcim.0c00169 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.4%
  6. 2018 Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties ACS Chemical Neuroscience YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.1%
  7. 2018 A QM protein–ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R) JOURNAL OF BIOMOLECULAR STRUCTURE DYNAMICS DOI 10.1080/07391102.2017.1365772 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.6%

Projects 2

  1. 2019 Yeni Monoamin Oksidaz-B Enzim İnhibitörlerinin Çok Boyutlu Bilgisayar Destekli İlaç Diyaznı Teknikleri ile Tasarlanması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2019-04-01 – 2020-09-24
  2. 2018 Monoamin Oksidaz-B Enzim İnhibitörü Moleküllerin Bilgisayar Ortamında Tasarımı ve İnhibitö-rProtein Etkileşimlerinin Kuantum Mekanik ve Moleküler Dinamik Yöntemlerle Aydınlatılması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2018-03-13 – 2020-01-01

Proceedings 9 See all (9) →

  1. 2019 Investigation of Role of Fluorine Atoms in the Activity of Well-Known Fluorine Containing Marketed Drugs: DFT and Docking Studies 7th International BAU Drug Design Congress
  2. 2019 Investigation of Role of Fluorine Atoms in the Activity of Well-Known Fluorine Containing Marketed Drugs: DFT and Docking Studies 7th International BAU Drug Design Congress
  3. 2018 Molecular Dynamics Simulation Studies on Homodimeric and Monomeric MAO-A and MAO-B Isomers in Different Media: Understanding of Lİgand Binding and Enzyme Selectivity 1st International Balkan Chemistry Congress
  4. 2018 Searching New MAO-B Hit Inhibitors with Integrated Computational Drug Design Methods 6. BAU Drug Design Congress
  5. 2020 A QM study for elucidation of interactions between BCR-ABL kinase protein and marketed drug molecules 3rd International Eurasian Conference on Biological and Chemical Sciences

Patents 2

  1. — A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES US 20230093302A1
  2. — A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES US 20230088611A1

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
10
With an akaturk profile
5
Turkish institutions
3
Co-authored works
%57

Academic co-authors 5

  1. MİNE YURTSEVER Profesör · İstanbul Teknik Üniversitesi 4
  2. SERDAR DURDAĞI Profesör · Bahçeşehir Üniversitesi 3
  3. AYŞEGÜL GÖLCÜ Profesör · İstanbul Teknik Üniversitesi 1
  4. FİLİZ ALTAY Profesör · İstanbul Teknik Üniversitesi 1
  5. MURAT ŞENTÜRK Profesör · Ağrı İbrahim Çeçen Üniversitesi 1

National collaboration 3 institutions

  1. İstanbul Teknik Üniversitesi 4 works · 3 academics
  2. Bahçeşehir Üniversitesi 3 works · 1 academics
  3. Ağrı İbrahim Çeçen Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 5

Busecan Aksoydan 2Pelin ŞenelRamin SalmasSoykan AğarTÜMCAN ŞEN

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.